Scientific article

L'apport de la génétique moléculaire en cardiologie clinique : l'exemple de la cardiomyopathie hypertrophique

Published inRevue médicale suisse, vol. 1, no. 21, p. 1448-1453
Publication date2005

Recent advances in molecular genetics have resulted in the identification of pathogenic mutations in a number of genes which cause hypertrophic cardiomyopathy (HCM). In order to integrate this increasing genetic knowledge of HCM into the cardiology clinic, we offer all patients and their families diagnosis and genetic counselling based on these current data. In addition, within the framework of a multidisciplinary project between the Divisions of Medical Genetics, Cardiology and Pediatric Cardiology of the University Hospitals of Geneva, we have developed a resequencing array enabling rapid molecular diagnosis of HCM. Data from this study will enhance our understanding of the aetiology of HCM, and improve our knowledge of genotype-phenotype correlations. This information will enable us to develop new therapeutic and preventive concepts, with the aim of tailoring therapies to the specific genetic variant of each patient and its family.

  • Cardiomyopathy, Hypertrophic/diagnosis/ genetics/therapy
  • Diagnosis, Differential
  • Genetic Counseling
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Humans
  • Molecular Biology/trends
Citation (ISO format)
FOKSTUEN, Siv et al. L’apport de la génétique moléculaire en cardiologie clinique : l’exemple de la cardiomyopathie hypertrophique. In: Revue médicale suisse, 2005, vol. 1, n° 21, p. 1448–1453.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation07/12/2010 2:36:11 PM
First validation07/12/2010 2:36:11 PM
Update time03/14/2023 3:53:44 PM
Status update03/14/2023 3:53:44 PM
Last indexation01/15/2024 8:47:40 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack